Cellply

Unraveling immune system function. One cell at a time.
Developing analytical systems to characterize next-generation cancer immunotherapy.

[Cellply @cellply]

Come to BOOTH #1961 and understand witness firsthand how 𝗩𝗶𝘃𝗮𝗖𝘆𝘁𝗲 𝗿𝗲𝗱𝗲𝗳𝗶𝗻𝗲𝘀 𝘁𝗵𝗲 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗼𝗳 #𝗰𝗲𝗹𝗹𝘂𝗹𝗮𝗿 #𝘁𝗵𝗲𝗿𝗮�#𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗮𝗻𝗮𝗹𝘆𝘁𝗶��𝘀.

#ASGCT2024 #CellTherapy #CancerResearch

[Cellply @cellply]

#ATW2024
Live at BOOTH 427 Richard Harbottle from @DKFZ https://t.co/pyRgGh8kNc

[Cellply @cellply]

#ATW2024 Join Evren Alici from @karolinskainst at 17 p.m to deepen studies of #NK #cell-based therapies using #insights from #multiparametric analysis
➡️Booth 427

[Cellply @cellply]

#ATW2024 Interactive session on how simultaneously determine potency of #CD4 #CD8 in a #CAR-T batch
Boot 427

[Cellply @cellply]

#ATW2024
Masterclass at our stand #427.
Join us to discover a novel unified #potencyscore
#celltherapy #advancedtherapiesweek

[Cellply @cellply]

Evren Alici Masterclass from @karolinskainst now at Booth 427 #ATW2024
#NK cell-based therapies

[Cellply @cellply]

A novel unified #potencyscore. Masterclass of @massimobocchi at #ATW2024
Booth 427

[Cellply @cellply]

Join Evren Alici from @karolinskainst speaking about #NK cell-based therapies
2.00 pm Booth 427 #ATW2024

[Cellply @cellply]

Measurement of #potency of novel #TCRTCELL therapies
Booth 427 at #ATW2024

[Cellply @cellply]

Starting our First Masterclass about #characterization of #celltherapy at #ATW2024

[Cellply @cellply]

Our team Héctor Gonzales and @massimobocchi showcasing a poster at #CICON23 conference, in collaboration with Dr. Richard Harbottle from @DKFZ German Cancer Research Center.
Stop by to see how we helped characterizing a novel TCR-T cell therapy with our VivaCyte platform.

[Cellply @cellply]

Unique opportunity to join @cellply as a PhD candidate working on #CARTcell characterization under the EU-funded OncoProTools project under the #MSCA action
#HorizonEurope #HorizonEU #research #Cancer #CancerResearch

[OncoProTools @ProOnco]

#OncoProTools is looking for 10 Doctoral Candidates (DC) in the fields of (Bio-)Chemistry, (Bio-)Engineering, Pharmaceutical Sciences, Molecular Biology, Medical Sciences, Biotechnology, Immunology and related disciplines (deadline: 15 JULY). Details 👉 https://t.co/iQnFlSniYJ

[🛠 Dev Startup Jobs @DevStartupJobs]

WANTED: Junior Automation & Test Engineer at @cellply (Bologna) https://t.co/v6kgZpoXUk

[Startupbusiness @Startupbusiness]

Schia Ventures partecipa al nuovo round di CellPly https://t.co/0Zpja1O6X3

[VentureUp @up_venture]

Schia Ventures entra nel capitale di @cellply

https://t.co/nlP88qJizK
#oncologia #healthtech #celltherapy #cellandgenetherapy #immunoterapia #startup #venturecapital

[Cellply @cellply]

Su La Repubblica Bologna di oggi intervista di Marco Bettazzi al CEO di Cellply @massimobocchi
@repubblica #celltherapy #cellandgenetherapy #atmp #cartcells #nkcells #covid #covid19research https://t.co/Rn1WkHmFLE

[Cellply @cellply]

We are #hiring
Check our positions in #software and #bioimage analysis areas to build software products for #AI powered high content image analysis and data visualization https://t.co/qGZmIVjfc0 #microscopy

[Cellply @cellply]

@cellply selected at the EIC Corporate Day with Marck will present today its innovation in deep single-cell characterization of #celltherapy and #immunotherapy #EUeic

[IAG @italianangels]

🚀II Riunione Soci #IAG 2021

Importante appuntamento con l'innovazione insieme ai nostri soci e ai founder delle startup: @massimobocchi - @cellply / Ciaran Burke -Swoop / Elisa Piscitelli e Mariapaola Testa - ORIENTAMI

#businessangel #startup #venturecapital

[Cellply @cellply]

@fattoquotidiano parla di noi #cancer #Leukemia #immunotherapy #PrecisionMedicine https://t.co/PamOcwvr1Q